Issue Price: Rs. 90 - Rs. 100 Per Equity Share


Allotment Status: http://www.linkintime.co.in/newsite/ipoInformation.jsp

Issue Detail:
»» Issue Open: Aug 16, 2011 - Aug 18, 2011
»» Issue Type: 100% Book Built Issue IPO
»» Issue Size: Equity Shares of Rs. 10
»» Issue Size: Rs. 63.00 Crore
»» Face Value: Rs. 10 Per Equity Share
»» Market Lot: 60 Shares
»» Minimum Order Quantity: 60 Shares
»» Listing At: BSE, NSE

Subscription Details:
Number of Times Issue is Subscribed (BSE + NSE)
As on Date & TimeQualified Institutional Buyers (QIBs)Non Institutional Investors (NIIs)Retail Individual Investors (RIIs)Total
Shares Offered / Reserved 3,500,000  1,050,000  2,450,000  7,000,000 
 Day 1 - Aug 16, 2011 17:00 IST 0.0000 0.0800 0.1900 0.0800 
 Day 2 - Aug 17, 2011 17:00 IST 0.0000 0.3300 0.6100 0.2600 
 Day 3 - Aug 18, 2011 17:00 IST 0.0000 2.8200 3.3600 1.6000 


Incorporated in 2002, Brooks Laboratories Ltd is in the business of Pharmaceutical Contract Research & Manufacturing. Company manufactures wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General Dry powder Injectables, Ampoules and Liquid vials, Dry Syrups and Tablets etc.

Brooks Labs has manufacturing unit at Baddi, Himachal Pradesh. Company has a world class team to develop new molecules in injectables and clavulanic acid based products supported by sophisticated infrastructure for Research & Development. Brooks Labs is WHO-GMP and ISO 9000-2008 certified company.

The Indian pharmaceuticals industry is significantly developed in terms of infrastructure, technology and product range in recent years. The country now ranks among the top four worldwide accounting for 8% to 10% of world’s production by volume and 1.5% to 2% by value.

Company Promoters:
The promoters of the company are:
1 Mr. Atul Ranchal
2 Mr. Rajesh Mahajan


Objects of the Issue:
The objects of the Issue are:
1. To set up our new manufacturing unit at JB SEZ Pvt Ltd, Panoli, Gujarat for manufacturing of various pharmaceuticals formulations.
2. To meet Long Term Working Capital requirement.
3. To meet General Corporate Purpose and
4. To meet Issue Expenses and Listing of Shares on Stock Exchanges.